7-Aminoheptanoic acid
Need Assistance?
  • US & Canada:
    +
  • UK: +

7-Aminoheptanoic acid

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

7-Aminoheptanoic Acid is an aliphatic ω-amino acid that acts as a ligand for recombinant kringle 2 domain (residues 180-261) of human tissue-type plasminogen.

Category
Other Unnatural Amino Acids
Catalog number
BAT-007884
CAS number
929-17-9
Molecular Formula
C7H15NO2
Molecular Weight
145.20
7-Aminoheptanoic acid
IUPAC Name
7-aminoheptanoic acid
Synonyms
7-Ahp-OH; 7-Aminoenanthic acid; omega-Aminoenantic acid; 7-Amino-heptanoic acid; HEPTANOIC ACID, 7-AMINO-; 7-Aminohepentanoic acid; Aminoenanthic acid; Amino-enanthylic acid; omega-Aminoheptanoic acid
Related CAS
62643-56-5 (hydrochloride)
Appearance
White to off-white crystalline powder
Purity
≥ 99%
Density
1.019±0.06 g/cm3 (Predicted)
Melting Point
187-190 °C
Boiling Point
270.6±23.0 °C (Predicted)
Storage
Store at RT
InChI
InChI=1S/C7H15NO2/c8-6-4-2-1-3-5-7(9)10/h1-6,8H2,(H,9,10)
InChI Key
XDOLZJYETYVRKV-UHFFFAOYSA-N
Canonical SMILES
C(CCCN)CCC(=O)O
1.Binding of angiogenesis inhibitor kringle 5 to its specific ligands by frontal affinity chromatography.
Bian L1, Li Q2, Ji X3. J Chromatogr A. 2015 Jul 3;1401:42-51. doi: 10.1016/j.chroma.2015.04.058. Epub 2015 May 7.
The interactions between angiogenesis inhibitor Kringle 5 and its five specific ligands were investigated by frontal affinity chromatography in combination with fluorescence spectra and site-directed molecular docking. The binding constants of trans-4-(aminomethyl) cyclohexane carboxylic acid (AMCHA), epsilon-aminocaproic acid (EACA), benzylamine, 7-aminoheptanoic acid (7-AHA) and L-lysine to Kringle 5 were 19.0×10(3), 7.97×10(3), 6.45×10(3), 6.07×10(3) and 4.04×10(3) L/mol, respectively. The five ligands bound to Kringle 5 on the lysine binding site in equimolar amounts, which was pushed mainly by hydrogen bond and Van der Waals force. This binding affinity was believed to be dependent on the functional group and flexible feature in ligands. This study will provide an important insight into the binding mechanism of angiogenesis inhibitor Kringle 5 to its specific ligands.
2.68Ga-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-d-Trp-Lys-Thr-Cys)).
AuthorsShan L.
3.Controllable Phase Separation by Boc-Modified Lipophilic Acid as a Multifunctional Extractant.
Tao K1, Adler-Abramovich L1,2, Gazit E1,3. Sci Rep. 2015 Dec 2;5:17509. doi: 10.1038/srep17509.
While phase separation of immiscible liquid-liquid systems has become increasingly significant in diverse areas, the irreversible nature limits their further application in controllable extraction-concentration or capture-release fields. There is a need for the development of simple, efficient and reversible methods for numerous research and industrial extraction and separation applications. We envisioned Boc-modified lipophilic acids as a simple model for such use based on the studies of the multi-phase transitions of Boc-modified supramolecular polymeric systems. Here, we demonstrate that in the presence of Boc-7-aminoheptanoic acid (Boc-7), phase separation occurs in mixtures of miscible organic solvent and water. The separation behavior was confirmed by differential colorimetric development in aqueous and organic phases using methyl orange staining assays. Component substitution experiments verified that the phase separation results from the subtle balance between the aggregation and the solvation forces of Boc-7, and is reversible by adjusting the solution pH.
4.Is there any need for a TAFI(a) inhibitor as thrombolytic drug?
Vercauteren E, Gils A. Thromb Res. 2012 Oct;130(4):574-5. doi: 10.1016/j.thromres.2012.07.010. Epub 2012 Jul 26.
Online Inquiry
Verification code
Inquiry Basket